DIF performed with a panel of immunoglobulins (IgG, IgA) and complement C3 is considered the gold standard in the diagnosis of MMP, but it has some limitations; it does not distinguish MMP from other subepithelial blistering diseases (BP or EBA). This evidence concerns the gene C3 and glycogen storage disease VI.